Tuesday, 17 Nov 2026
Subscribe
logo logo
  • Global
  • Technology
  • Business
  • AI
  • Cloud
  • Edge Computing
  • Security
  • Investment
  • More
    • Sustainability
    • Colocation
    • Quantum Computing
    • Regulation & Policy
    • Infrastructure
    • Power & Cooling
    • Design
    • Innovations
  • 🔥
  • data
  • revolutionizing
  • Stock
  • Investment
  • Future
  • Secures
  • Top
  • Growth
  • Funding
  • Power
  • Center
  • technology
Font ResizerAa
Silicon FlashSilicon Flash
Search
  • Global
  • Technology
  • Business
  • AI
  • Cloud
  • Edge Computing
  • Security
  • Investment
  • More
    • Sustainability
    • Colocation
    • Quantum Computing
    • Regulation & Policy
    • Infrastructure
    • Power & Cooling
    • Design
    • Innovations
Have an existing account? Sign In
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Silicon Flash > Blog > Investments > GenrAb Closes $5.6M Seed Financing
Investments

GenrAb Closes $5.6M Seed Financing

Published April 22, 2025 By Juwan Chacko
Share
1 Min Read
GenrAb Closes .6M Seed Financing
SHARE

GenrAb Raises $5.6M in Seed Funding for Development of Neuroprotective Therapies

GenrAb, a Dallas, TX-based company specializing in the development of neuroprotective therapies, has secured $5.6 million in Seed funding.

The funding round was led by Actium Group.

GenrAb plans to utilize the investment to expedite the progress of its primary candidate, TGM-010, which is a novel neuroprotective antibody that is fully human.

Headed by CEO Larry Tiffany, GenrAb is focused on the research and creation of neuroprotective and neurotherapeutic human antibodies. Using its unique immunogenetic models, the company analyzes cerebrospinal fluid from patients with active neurological conditions to extract new human antibodies associated with diseases. These antibodies, including TGM-010, are chosen based on their ability to protect neurons and their potential to manage neuronal stress, thereby preserving cell function and viability. Through this innovative approach, GenrAb is establishing a portfolio of patented therapeutic antibodies that can effectively reduce disability in individuals suffering from neurodegenerative disorders. This effort aims to make rare antibodies, typically only found in specific patients with neurological illnesses, more widely accessible.

FinSMEs

22/04/2025

See also  Should You Invest in Rigetti Computing Stock?
TAGGED: 5.6M, Closes, Financing, GenrAb, Seed
Share This Article
Facebook LinkedIn Email Copy Link Print
Previous Article Sustainability of 5 Different DC and IT Layers – Software Sustainability of 5 Different DC and IT Layers – Software
Next Article TBD VC unveils M venture fund to back Israeli deep tech startups TBD VC unveils $35M venture fund to back Israeli deep tech startups
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.
FacebookLike
LinkedInFollow

Popular Posts

Pixel 10 Unveils Major Charging Upgrade: Qi2 Integration on the Horizon

The upcoming Google Pixel 10 phones are on the brink of their official debut, and…

August 18, 2025

The Top Reason to Invest in XRP Right Now

Summary: XRP has experienced recent pullbacks due to delays in SEC decisions and concerns about…

August 24, 2025

How Much Do You Really Know?

Data centers can be deceivingly simple. To the uninitiated, they’re simply large buildings that host…

April 21, 2025

The Two-Faced Future of AI Investing

AI's rise to prominence is transforming industries and investment strategies, shaping the future of society…

August 27, 2025

Revolutionizing Retail: How RFID is Fueling Amazon’s Autonomous Technology

Summary: New RFID lanes are specifically designed for merchandise and apparel to improve tracking accuracy…

January 22, 2026

You Might Also Like

Braidwell’s  Million Investment Fuels BrightSpring’s 86% Stock Surge in Healthcare Services
Investments

Braidwell’s $45 Million Investment Fuels BrightSpring’s 86% Stock Surge in Healthcare Services

SiliconFlash Staff
The Soaring Success of Lockheed Martin Stock Today
Investments

The Soaring Success of Lockheed Martin Stock Today

Juwan Chacko
Driving Innovation: Visteon’s Q4 2025 Earnings Report
Investments

Driving Innovation: Visteon’s Q4 2025 Earnings Report

Juwan Chacko
Record High Imports in 2025: Is the U.S. Trade Deficit Tariff-Proof?
Investments

Record High Imports in 2025: Is the U.S. Trade Deficit Tariff-Proof?

SiliconFlash Staff
logo logo
Facebook Linkedin Rss

About US

Silicon Flash: Stay informed with the latest Tech News, Innovations, Gadgets, AI, Data Center, and Industry trends from around the world—all in one place.

Top Categories
  • Technology
  • Business
  • Innovations
  • Investments
Usefull Links
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 – siliconflash.com – All rights reserved

Welcome Back!

Sign in to your account

Lost your password?